EyeGene Inc.

KOSDAQ:A185490 Stock Report

Market Cap: ₩77.3b

EyeGene Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Won-Il Yoo

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenure24.4yrs
CEO ownership4.8%
Management average tenureno data
Board average tenureno data

Recent management updates

No updates

Recent updates

Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Jul 26
Health Check: How Prudently Does EyeGene (KOSDAQ:185490) Use Debt?

Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

Mar 29
Does EyeGene (KOSDAQ:185490) Have A Healthy Balance Sheet?

EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Feb 01
EyeGene's (KOSDAQ:185490) Stock Price Has Reduced 51% In The Past Five Years

Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

Dec 07
Is EyeGene (KOSDAQ:185490) Using Debt In A Risky Way?

CEO

Won-Il Yoo

24.4yrs

Tenure

Mr. Won-Il Yoo has been Chief Executive Officer of EyeGene, Inc. since June 2000. Mr. Yoo has directed EyeGene's initial financing, set-up, recruiting, R&D and business development. He has over 12 years re...